Viewing Study NCT04601857


Ignite Creation Date: 2025-12-24 @ 7:01 PM
Ignite Modification Date: 2025-12-29 @ 8:31 PM
Study NCT ID: NCT04601857
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-03-04
First Post: 2020-10-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
Sponsor: Taiho Oncology, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module